|
336
|
825
|
2qrhA |
Glycogen phosphorylase b in complex with (1r)-3'-phenylspiro[1,5-anhydro-d-glucitol-1,5'-isoxazoline] |
|
330
|
825
|
2qn1A |
Glycogen phosphorylase b in complex with asiatic acid |
|
338
|
826
|
2pydA |
The crystal structure of glycogen phosphorylase in complex with glucose at 100 k |
|
341
|
826
|
2qrpA |
Glycogen phosphorylase b in complex with (1r)-3'-(2-naphthyl)-spiro[1,5-anhydro-d-glucitol-1,5'-isoxazoline] |
|
337
|
825
|
2qn8A |
Glycogen phosphorylase b in complex with n-4-nitrobenzoyl-n'-beta-d-glucopyranosyl urea |
|
336
|
825
|
2qlnA |
Glycogen phosphorylase b in complex with n-4-phenylbenzoyl-n'-beta-d-glucopyranosyl urea |
|
338
|
825
|
2qlmA |
Glycogen phosphorylase in complex with fn67 |
|
336
|
826
|
2pyiA |
Crystal structure of glycogen phosphorylase in complex with glucosyl triazoleacetamide |
|
336
|
826
|
2qnbA |
Glycogen phosphorylase b in complex with n-benzoyl-n'-beta-d-glucopyranosyl urea |
|
336
|
825
|
2qrmA |
Glycogen phosphorylase b in complex with (1r)-3'-(4-nitrophenyl)-spiro[1,5-anhydro-d-glucitol-1,5'-isoxazoline] |
|
326
|
830
|
2prjA |
Binding of n-acetyl-beta-d-glucopyranosylamine to glycogen phosphorylase b |
|
291
|
835
|
2qllA |
Human liver glycogen phosphorylase- gl complex |
|
331
|
830
|
2priA |
Binding of 2-deoxy-glucose-6-phosphate to glycogen phosphorylase b |
|
337
|
824
|
2iegA |
Crystal structure of rabbit muscle glycogen phosphorylase in complex with 3,4-dihydro-2-quinolone |
|
327
|
820
|
2ieiA |
Crystal structure of rabbit muscle glycogen phosphorylase in complex with 3,4-dihydro-2-quinolone |
|
336
|
825
|
2gm9A |
Structure of rabbit muscle glycogen phosphorylase in complex with thienopyrrole |
|
342
|
824
|
2gpnA |
100 k structure of glycogen phosphorylase at 2.0 angstroms resolution |
|
334
|
834
|
2gpaA |
Allosteric inhibition of glycogen phosphorylase a by a potential antidiabetic drug |
|
334
|
831
|
2gpbA |
Comparison of the binding of glucose and glucose-1-phosphate derivatives to t-state glycogen phosphorylase b |
|
339
|
824
|
2gj4A |
Structure of rabbit muscle glycogen phosphorylase in complex with ligand |
|
340
|
825
|
2g9rA |
The crystal structure of glycogen phosphorylase b in complex with (3r,4r,5r)-5-hydroxymethyl-1-(3-phenylpropyl)-piperidine-3,4-diol |
|
326
|
824
|
2g9vA |
The crystal structure of glycogen phosphorylase in complex with (3r,4r,5r)-5-hydroxymethylpiperidine-3,4-diol and phosphate |
|
323
|
823
|
2g9uA |
The crystal structure of glycogen phosphorylase in complex with (3r,4r,5r)-5-hydroxymethyl-1-(3-phenylpropyl)-piperidine-3,4-diol and phosphate |
|
321
|
825
|
2g9qA |
The crystal structure of the glycogen phosphorylase b- 1ab complex |
|
342
|
825
|
2f3qA |
Crystal structure of the glycogen phosphorylase b / methyl-n-(beta-d-glucopyranosyl)oxamate complex |
|
344
|
825
|
2ff5A |
Synthesis of c-d-glycopyranosyl-hydroquinones and-benzoquinones. inhibition of ptp1b. inhibition of and binding to glycogen phosphorylase in the crystal |
|
340
|
825
|
2f3pA |
Crystal structure of the glycogen phosphorylase b / n-(beta-d-glucopyranosyl)oxamic acid complex |
|
342
|
825
|
2ffrA |
Crystallographic studies on n-azido-beta-d-glucopyranosylamine, an inhibitor of glycogen phosphorylase: comparison with n-acetyl-beta-d-glucopyranosylamine |
|
342
|
825
|
2f3sA |
Crystal structure of the glycogen phosphorylase b / ethyl-n-(beta-d-glucopyranosyl)oxamate complex |
|
337
|
825
|
2fetA |
Synthesis of c-d-glycopyranosyl-hydroquinones and-benzoquinones. inhibition of ptp1b. inhibition of and binding to glycogen phosphorylase in the crystal |
|
341
|
825
|
2f3uA |
Crystal structure of the glycogen phosphorylase b / n-(beta-d-glucopyranosyl)-n'-cyclopropyl oxalamide complex |
|
307
|
796
|
2ecpA |
The crystal structure of the e. coli maltodextrin phosphorylase complex |
|
327
|
788
|
2c4mA |
Starch phosphorylase: structural studies explain oxyanion-dependent kinetic stability and regulatory control. |
|
338
|
796
|
2av6A |
X-ray studies on maltodextrin phosphorylase complexes: recognition of substrates and cathalitic mechanism of phosphorylase family |
|
325
|
809
|
2atiA |
Glycogen phosphorylase inhibitors |
|
335
|
796
|
2aw3A |
X-ray studies on maltodextrin phosphorylase complexes: recognition of substrates and cathalitic mechanism of phosphorylase family |
|
321
|
796
|
2azdA |
X-ray studies on maltodextrin phosphorylase (malp) complexes: recognition of substrates and catalytic mechanism of phosphorylase family |
|
336
|
796
|
2asvA |
X-ray studies on protein complexes: enzymatic catalysis in crystals of e. coli maltodextrin phosphorylase (malp) |
|
334
|
829
|
2amvA |
The structure of glycogen phosphorylase b with an alkyl-dihydropyridine-dicarboxylic acid |
|
338
|
829
|
1z6qA |
Glycogen phosphorylase with inhibitor in the amp site |
|
342
|
829
|
1z6pA |
Glycogen phosphorylase amp site inhibitor complex |
|
337
|
826
|
1z62A |
Indirubin-3'-aminooxy-acetate inhibits glycogen phosphorylase by binding at the inhibitor and the allosteric site. broad specificities of the two sites |
|
327
|
835
|
1z8dA |
Crystal structure of human muscle glycogen phosphorylase a with amp and glucose |
|
317
|
876
|
1ygpA |
Phosphorylated form of yeast glycogen phosphorylase with phosphate bound in the active site. |
|
342
|
825
|
1xl0A |
Kinetic and crystallographic studies on 2-(beta-d-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. evidence for a new binding site. |
|
321
|
816
|
1xoiA |
Human liver glycogen phosphorylase a complexed with chloroindoloyl glycine amide |
|
343
|
825
|
1xl1A |
Kinetic and crystallographic studies on 2-(beta-d-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. evidence for a new binding site. |
|
341
|
825
|
1xkxA |
Kinetic and crystallographic studies on 2-(beta-d-glucopyranosyl)-5-methyl-1,3,4-oxadiazole,-benzothiazole, and-benzimidazole, inhibitors of muscle glycogen phosphorylase b. evidence for a new binding site. |
|
337
|
826
|
1ww3A |
Crystallographic studies on two bioisosteric analogues, n-acetyl-beta-d-glucopyranosylamine and n-trifluoroacetyl-beta-d-glucopyranosylamine, potent inhibitors of muscle glycogen phosphorylase |
|
326
|
825
|
1wutA |
Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes |
